Treatment of glaucoma continues to be directed at lowering intraocular pres
sure to decrease the likelihood of disease progression. In the future intra
ocular pressure reduction might be augmented by other therapeutic approache
s. interest has been increasing in preventing progression of glaucomatous o
ptic neuropathy using approaches based on the premise that glaucoma is a ne
urodegenerative disease, Neuroprotection of the glaucomatous optic nerve th
erefore would be an adjuctive therapeutic paradigm for use with conventiona
l intraocular pressure-lowering treatments or by itself.